Foundation Medicine, Inc. Company Profile

06:21 EDT 24th March 2018 | BioPortfolio

Foundation Medicine (NASDAQ: FMI) is a molecular information company focused on fundamentally changing the way patients with cancer are treated. Our proprietary molecular information platform generates actionable genomic information about a patient’s individual cancer, enabling physicians to optimize treatments in clinical practice and enabling biopharmaceutical companies to develop targeted oncology therapies more effectively. The Company’s first clinical product, FoundationOne™, is the first commercially available comprehensive molecular information product designed for use in the routine care of patients with cancer.

Molecular subtypes of cancer

As the molecular drivers of cancer are better understood and more targeted therapies are developed against those drivers, there is an ever-growing need to perform comprehensive molecular analysis of tumors to determine the optimal treatment strategy for each patient. Foundation Medicine is pioneering the development of a comprehensive cancer diagnostic test that represents this critical step toward individualized cancer care by helping physicians recommend treatment options for each patient based on the molecular subtype of their cancer.

A new, cutting edge diagnostic approach

By utilizing next-generation sequencing on small amounts of cancer tissue, relevant genomic information that will help doctors make the most informed treatment recommendations will be captured in one test with greater than 99% sensitivity and specificity for alterations within all relevant cancer genes. Test results will be uniquely reported within the context of publicly available scientific and medical literature and clinical trials, integrating complex genomic research in a coordinated and easily accessible way for physicians to inform treatment recommendations.


One Kendall Square, Suite B3501


Phone: 617-418-2200
Fax: 617-418-2201

News Articles [1090 Associated News Articles listed on BioPortfolio]

Foundation Medicine Advances Patient Access to Precision Medicine; Pursues Regulatory Approval ...

-- Chugai to Commercialize Foundation Medicine’s Suite of Comprehensive Genomic Profiling (CGP) Services in Japan, Expanding Patient Access to Personalized Cancer Care -- Read mor...

Pfizer Joins Foundation Medicine to Develop Cancer CDx

Foundation Medicine said today it will partner with Pfizer to develop and commercialize companion diagnostics (CDx) for the pharma giant’s oncology portfolio, through a collaboration whose value was...

Foundation Medicine to Present at Cowen and Company’s 38th Annual Healthcare Conference

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that members of the company's management team will present at Cowen & Company’s 38th Annual Healthcare Conferen...

Foundation Medicine's NGS-based test wins FDA nod, proposed CMS coverage

Foundation Medicine's FoundationOne CDx NGS-based molecular profiling test has obtained approval from the FDA, as well as pro -More- 

Foundation Medicine gets FDA nod for pan-tumour comprehensive genomic profiling assay

Roche’s molecular information firm Foundation Medicine has secured approval from the US Food and Drug Administration (FDA) for FoundationOne CDx comprehensive companion diagnostic assay for personal...

Caris Life Sciences Files Patent Infringement Suit against Foundation Medicine, Inc.

According to the complaint, Foundation Medicine infringes five U.S. Patents (Nos. 8,880,350; 9,372,193; 9,383,365; 9,092,392; and 9,292,660) held by Caris. The patents cover Caris' novel Read more...

Roche's Foundation Medicine wins FDA blessing for new cancer test

ZURICH (Reuters) - Roche on Monday said its Foundation Medicine unit won U.S. Food and Drug Administration (FDA) approval for a test to help doctors understand the genetic profile of patients' tumors ...

Active-Investors: Blog Exposure - Foundation Medicine Collaborated with Chugai for Commercialization of FoundationOne CDx in Japan

Stock Monitor: Miragen Therapeutics Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 20, 2018 / has just released a free research report on Foundation Medicine, Inc. (NAS...

Drugs and Medications [699 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

Clinical Trials [1397 Associated Clinical Trials listed on BioPortfolio]

Olive Oil v Prostate Cancer Foundation Diet for Treatment of Prostate Cancer

This study compared a plant-based, olive oil diet to the diet recommended by the Prostate Cancer Foundation for weight loss and improvement in some laboratory biomarkers.

Concordance Between ctDNA Assay and FoundationOne

Foundation Medicine Inc. (FMI) is interested in studying the concordance of genomic alterations between primary and/or metastatic surgical biopsies, and circulating tumor DNA (ctDNA) withi...

Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary

The goal of the current study is to determine whether Foundation Medicine's next generation sequencing assay, called FoundationOne, will provide information that allows physicians to make ...

The Promotion Plan of Moxibustion on Ulcerate Colitis

To evaluate the efficacy of Moxibustion in the treatment of Ulcerative Colitis, thus the scientific foundation for rational use of Moxibustion in clinical usage, in order to find admission...

Mechanism of Drug-drug Interaction Between Salvianolate Injection and Aspirin

The combination of anti-platelet medicine treatment and Chinese traditional medicine (TCM) promoting blood circulation to removing blood stasis is widely used in treatment for cardiovascul...

Companies [2350 Associated Companies listed on BioPortfolio]

The Medco Foundation

The Medco Foundation was established with the generous support of Medco Health Solutions, Inc. The Foundation focuses on supporting activities aimed at educating and informing the general public about...

Foundation Medicine, Inc. and WuXi PharmaTech

Foundation Medicine (NASDAQ: FMI) is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the gen...

The Foundation for Mitochondrial Medicine

The Foundation for Mitochondrial Medicine is a 501(c) (3) non-profit organization dedicated to supporting the development of the most promising research and treatments of the many...

Northwestern Medical Faculty Foundation

Northwestern Medical Faculty Foundation, Inc. (the Foundation) is a premier, multi-specialty physician organization committed to providing high quality care to patients, and to supporting the research...

The Alzheimer’s Drug Discovery Foundation (ADDF) and the Foundation for Mitochondrial Medicine (FMM)

More Information about "Foundation Medicine, Inc." on BioPortfolio

We have published hundreds of Foundation Medicine, Inc. news stories on BioPortfolio along with dozens of Foundation Medicine, Inc. Clinical Trials and PubMed Articles about Foundation Medicine, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Foundation Medicine, Inc. Companies in our database. You can also find out about relevant Foundation Medicine, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record